ClinConnect ClinConnect Logo
Search / Trial NCT05863013

Use of the ADL-Glittre Test in the Pre and Postoperative Period of Patients With Lung Cancer

Launched by CENTRO UNIVERSITÁRIO AUGUSTO MOTTA · May 8, 2023

Trial Information

Current as of July 23, 2025

Enrolling by invitation

Keywords

Adl Glittre Test Functional Capacity Pulmonary Rehabilitation Lung Cancer

ClinConnect Summary

In the population of patients with lung cancer, two critical points that constitute gaps in the literature are: 1) the definition of operability using only pulmonary function tests and the consequent preparation of the patient for the surgical act; and 2) the postoperative approach and the consequent screening aimed at improving quality of life and reducing morbidity. In addition to the sophistication of pulmonary rehabilitation that has occurred in recent decades, the ADL-Glittre test was also developed, which is a measure of submaximal effort that assesses functional capacity and encompas...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of NSCLC stages I to IV, that is, those patients without evidence of mediastinal disease or local organ invasion.
  • Age equal to or greater than 18 years.
  • The following types of lung surgery: pneumonectomy, bilobectomy, lobectomy, segmentectomy and wedge resection.
  • Resection by thoracotomy or video-assisted thoracoscopic surgery.
  • Exclusion Criteria:
  • Patients known to need adjuvant treatments.
  • Show inability to walk.
  • Not being able to perform pulmonary function tests and/or functional tests.
  • Presence of cardiovascular, neurological or orthopedic diseases.
  • Bronchopleural fistula, sudden increase in chest drainage or active intrathoracic hemorrhage, chylothorax or other serious adverse events.

About Centro Universitário Augusto Motta

Centro Universitário Augusto Motta (CEHAM) is a distinguished higher education institution in Brazil, dedicated to advancing medical research and clinical trials. With a strong emphasis on innovation and scientific excellence, CEHAM fosters an environment that encourages collaboration among health professionals, researchers, and students. The institution is committed to conducting rigorous clinical studies that contribute to the enhancement of healthcare practices and the development of new therapies. CEHAM’s multidisciplinary approach and adherence to ethical standards ensure that its clinical trials are conducted with the utmost integrity, aiming to improve patient outcomes and drive forward the frontiers of medical knowledge.

Locations

Rio De Janeiro, , Brazil

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported